Drd4 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Attribute | Value | [@oak2000] |-----------|-------| [@nakajima2013] | Protein Name | Dopamine Receptor D4 | [@faraone2014] | Gene Symbol | [drd4](/proteins/drd4-protein) | | UniProt ID | [P21970](https://www.uniprot.org/uniprot/P21970) | | Molecular Weight | ~48-55 kDa | | Subcellular Localization | Plasma membrane, dendritic spines | | Protein Family | D2-like dopamine receptor family (GPCR) | | Signal Transduction | Gi/o protein-coupled, inhibits adenylate cyclase |
</div>}
Overview
The Dopamine Receptor D4 (DRD4) is a G protein-coupled receptor encoded by the [DRD4](/proteins/drd4-protein) gene. It belongs to the D2-like family and is characterized by particularly high polymorphism in humans, with variants associated with various behavioral traits and neuropsychiatric conditions. DRD4 is expressed in prefrontal [cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), and hypothalamus, where it modulates cognitive functions, attention, and reward-motivated behavior.
Structure
DRD4 exhibits the classic seven-transmembrane GPCR fold with unique features:
...
Dopamine Receptor D4 Protein
Introduction
Drd4 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Attribute | Value | [@oak2000] |-----------|-------| [@nakajima2013] | Protein Name | Dopamine Receptor D4 | [@faraone2014] | Gene Symbol | [drd4](/proteins/drd4-protein) | | UniProt ID | [P21970](https://www.uniprot.org/uniprot/P21970) | | Molecular Weight | ~48-55 kDa | | Subcellular Localization | Plasma membrane, dendritic spines | | Protein Family | D2-like dopamine receptor family (GPCR) | | Signal Transduction | Gi/o protein-coupled, inhibits adenylate cyclase |
</div>}
Overview
The Dopamine Receptor D4 (DRD4) is a G protein-coupled receptor encoded by the [DRD4](/proteins/drd4-protein) gene. It belongs to the D2-like family and is characterized by particularly high polymorphism in humans, with variants associated with various behavioral traits and neuropsychiatric conditions. DRD4 is expressed in prefrontal [cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), and hypothalamus, where it modulates cognitive functions, attention, and reward-motivated behavior.
Structure
DRD4 exhibits the classic seven-transmembrane GPCR fold with unique features:
48-base pair variable number tandem repeat (VNTR): The third intracellular loop contains a polymorphic 48-bp repeat (2-11 copies) that affects G protein coupling efficiency
Alternative splicing: Produces multiple isoforms with differential signaling properties
N-linked glycosylation sites: Located in the N-terminus for proper protein folding
The 7-repeat allele is the most common, while shorter variants show enhanced receptor signaling.
Normal Function
DRD4 mediates essential functions in the central nervous system:
Attention and cognition: Prefrontal cortex expression modulates working memory and attentional processes
Impulse control: Striatal and cortical expression influences response inhibition
Reward processing: Limbic system involvement in novelty-seeking and reward anticipation
neurodegeneration" style="color:#4fc3f7;margin:1.5rem 0 0.6rem;font-size:1.15rem;font-weight:700;border-bottom:2px solid rgba(79,195,247,0.3);padding-bottom:0.3rem">Role in Neurodegeneration
Parkinson's Disease
DRD4 alterations contribute to cognitive dysfunction in PD. Post-mortem studies show reduced DRD4 binding in prefrontal cortex, correlating with executive dysfunction. DRD4 polymorphisms may influence PD susceptibility and treatment response.
Attention-Deficit/Hyperactivity Disorder (ADHD)
DRD4 7-repeat allele is one of the most replicated genetic associations with ADHD. This variant affects dopamine signaling in prefrontal circuits governing attention and impulse control.
Alzheimer's Disease
DRD4 is implicated in memory consolidation through hippocampal signaling. Altered DRD4 expression has been reported in AD brains, potentially affecting cholinergic-dopaminergic interactions.
Therapeutic Targeting
| Drug Class | Examples | Mechanism | Status | |-----------|----------|-----------|--------| | DRD4 Agonists | ABT-724, ABT-670 | Selective receptor activation | Research phase | | DRD4 Antagonists | L-745,870 | Block receptor signaling | Research phase |
Research Directions
Development of DRD4-selective compounds for cognitive enhancement
Understanding VNTR polymorphism effects on receptor pharmacology
PET ligand development for in vivo receptor imaging
Background
The study of Drd4 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.